SCHEMBL9905089

SCHEMBL9905089

O=C(CNC(=O)c1nc2n(c(=O)c1OCc1ccccc1)CC1CCC2(NC(=O)O)CC1)Cc1ccc(F)cc1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM4 P08173 1/20 0.34
SMN1; SMN2 Q16637 2/20 0.33
CTSL P07711 1/20 0.33
LMNA P02545 3/20 0.33
MAPT P10636 2/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
ALDH1A1 P00352 3/20 0.32
HPGD P15428 1/20 0.32
CNR2 P34972 2/20 0.32
ADORA2A P29274 1/20 0.32
ADORA1 P30542 1/20 0.32
PRKAA2 P54646 1/20 0.32
RCE1 Q9Y256 1/20 0.32
MEN1 O00255 2/20 0.31
KMT2A Q03164 2/20 0.31
RXFP1 Q9HBX9 1/20 0.31
CNR1 P21554 1/20 0.31
GRM5 P41594 1/20 0.31
RAB9A P51151 1/20 0.31
KDM1A O60341 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14214192 0.94 ALDH1A1 (0.34) CHRM4SMN1; SMN2CTSLLMNAMAPT
SCHEMBL9905158 0.91 CYP2C9 (0.34) CHRM4SMN1; SMN2CTSLLMNAMAPT
SCHEMBL9905325 0.90 SIGMAR1 (0.35) CHRM4SMN1; SMN2CTSLLMNAALDH1A1
SCHEMBL9921564 0.87 TLR2 (0.35) CHRM4MAPTL3MBTL1ALDH1A1HPGD
SCHEMBL14122411 0.86 CHRM4 (0.33) CHRM4CTSLLMNAMAPTL3MBTL1
SCHEMBL9905376 0.84 OPRM1 (0.35) SMN1; SMN2MAPTALDH1A1HPGDCNR2
SCHEMBL14214197 0.83 ALDH1A1 (0.34) CHRM4SMN1; SMN2CTSLLMNAMAPT
SCHEMBL9905381 0.83 CTSL (0.39) CHRM4SMN1; SMN2CTSLALDH1A1HPGD
SCHEMBL9921566 0.80 CYP2C9 (0.34) CNR2
SCHEMBL64360 0.78 CYP2C9 (0.40) CHRM4SMN1; SMN2LMNAMAPTL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2649074-A1 HIV INTEGRASE INHIBITORS Bristol-Myers Squibb Company (US) 2013-10-16 EP disclosed
WO-2012078844-A1 HIV INTEGRASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2012-06-14 WO disclosed